e-learning
resources
Vienna 2003
Sunday 28.09.2003
Epidemiology, therapy and outcome of infections in the ICU
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia
M. Cavalcanti, M. Ioanas, M. Ferrer, R. Ferrer, C. Agusti, J. Puig, A. Torres (Barcelona, Spain; Bucharest, Romania)
Source:
Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Session:
Epidemiology, therapy and outcome of infections in the ICU
Session type:
Oral Presentation
Number:
230
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Cavalcanti, M. Ioanas, M. Ferrer, R. Ferrer, C. Agusti, J. Puig, A. Torres (Barcelona, Spain; Bucharest, Romania). Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia. Eur Respir J 2003; 22: Suppl. 45, 230
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Source: Eur Respir J 2003 Dec 01;22(6):876-882
Year: 2003
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: Guideline 2018
Year: 2019
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018
Year: 2018
Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
Source: Eur Respir J 2008; 32: 892-901
Year: 2008
Adherence to guidelines and clinical stability in community-acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004
Impact of guidelines on HAP and VAP outcomes
Source: Eur Respir Mon 2011; 53: 66-73
Year: 2011
Validation of the ATS/IDSA guidelines for ICU-acquired pneumonia
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017
Year: 2017
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Guideline 2017
Year: 2017
International Guideline concordance of empiric antibiotic use in community-acquired pneumonia
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011
Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Validation of treatment failure criteria of nosocomial pneumonia in ICU
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011
Verifying the antibiotic selection algorithm in the new Japanese pneumonia guidelines - Is algorithm-discordant treatment associated with increased mortality of healthcare-associated pneumonia?
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Cost minimization for community-acquired pneumonia management in Belarussian hospital from implementation of clinical guidelines
Source: Eur Respir J 2005; 26: Suppl. 49, 258s
Year: 2005
Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis
Source: Eur Respir J 2011; 37: 858-864
Year: 2011
From international guidelines to local guidelines for nosocomial pneumonia: what is missing?
Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept